Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-09, Stock:NVO, The news for the past five days is as follows:
2018-02-02: NEWS1: Novartis’s 4Q17 Earnings: Segment-Wise Revenues.NEWS2: AstraZeneca’s 4Q17 Earnings: Analyst Estimates.NEWS3: Validea Peter Lynch Strategy Daily Upgrade Report - 2/2/2018.NEWS4: Validea Peter Lynch Strategy Daily Upgrade Report - 2/2/2018.NEWS5: Validea John Neff Strategy Daily Upgrade Report - 2/2/2018.NEWS6: Validea John Neff Strategy Daily Upgrade Report - 2/2/2018.
2018-02-05: NEWS1: Novo Nordisk plans $65M expansion in Johnston County.NEWS2: Foreign Stock Roundup: RDS.A & AZN Impress, NVO & BABA Disappoint.NEWS3: Foreign Stock Roundup: RDS.A & AZN Impress, NVO & BABA Disappoint.NEWS4: Novartis’s 4Q17 Earnings: Alcon Business.NEWS5: Foreign Stock Roundup: RDS.A & AZN Impress, NVO & BABA Disappoint.NEWS6: Novartis’s 4Q17 Earnings: Sandoz Business.NEWS7: Wired News – Teva Pharma Announced the Acceptance of Fremanezumab’s Marketing Authorization Application by EMA.
2018-02-06: NEWS1: Novo Nordisk's Dichotomy Abounds.NEWS2: Novo Nordisk's Dichotomy Abounds.NEWS3: Novo Nordisk&apos;s Dichotomy Abounds.NEWS4: FOCUS-In diabetes war, Novo Nordisk aims to break mould with new pill.NEWS5: Analysts’ Recommendations for Novartis after Its 4Q17 Earnings.
2018-02-07: NEWS1: Sanofi Leads the Hemophilia Space on Bioverativ Acquisition.
2018-02-08: NEWS1: A Look at Ablynx and Sanofi’s Existing Partnership.NEWS2: Highlights of Sanofi’s 3.9 Billion Euro Ablynx Acquisition.NEWS3: Analysts’ Updates after Sanofi’s Bioverativ Announcement.

Answer: Rise